![]() |
市場調查報告書
商品編碼
1880423
2032年農業合成生物學市場預測:按作物類型、投入類型、部署模式、技術、應用、最終用戶和地區分類的全球分析Synthetic Biology in Agriculture Market Forecasts to 2032 - Global Analysis By Crop Type, Input Type, Mode of Deployment, Technology, Application, End User and By Geography |
||||||
根據 Stratistics MRC 的數據,預計 2025 年全球農業合成生物學市場規模將達到 82 億美元,到 2032 年將達到 827 億美元,預測期內複合年成長率將達到 38.9%。
農業合成生物學是一門交叉學科,它結合了生物學、工程學和計算科學,旨在設計和建造新型生物系統或改造現有生物體以用於農業生產。這項技術專注於培育具有改良性狀的作物,例如提高產量、增強抗病蟲害能力、耐旱性和最佳化營養吸收。透過改造微生物、植物和酶,合成生物學還可以改善土壤健康、實現永續肥料生產並開發生物基農藥。此方法旨在利用精準且可程式設計的生物解決方案,提高農業效率、減少環境影響並保障糧食安全。
對永續作物生產的需求不斷成長
農民和農業相關企業正在加速採用合成生物學解決方案,以減少對化學投入的依賴並提高資源利用效率。基因改造種子和微生物解決方案能夠在最大限度減少環境影響的同時提高產量,符合全球永續性目標。消費者對環保食品生產方式日益成長的偏好也推動了合成生物學技術的應用。各國政府和國際組織正在推廣永續農業實踐,這進一步增強了對創新生物工具的需求。合成生物學培育適應性強的作物的能力有助於保障長期糧食安全。
小規模農戶意識水平低
許多農民仍然不熟悉合成生物學的應用和益處,這減緩了分散農業系統中技術的普及。缺乏培訓和推廣服務進一步加劇了這項挑戰。科技的複雜性和人們感知到的風險阻礙了小規模農戶嘗試基因改造解決方案。在以傳統耕作方式為主的新興經濟體中,認知度低也限制了需求。如果沒有針對性的教育和推廣,合成生物學的應用將仍然僅限於大型商業農場。
對抗蟲作物品種的需求日益成長
合成生物學能夠開發基因改造種子和微生物性狀,進而增強作物對病蟲害的抵抗力。氣候變遷和病蟲害壓力不斷加劇導致作物損失日益增加,推動了對這些解決方案的需求。農民受益於農藥用量減少、成本降低和產量提高,從而促進了這些技術的應用。基因工程和CRISPR技術的進步正在加速病蟲害抗性狀的創新。各國政府和研究機構正支持相關研發項目,以增強糧食安全。
基因改造作物引發的倫理問題
消費者對基因工程的懷疑態度以及對生物多樣性風險的擔憂限制了其在一些地區的接受度。倡導團體經常表達對長期生態影響的擔憂,這延緩了監管核准流程。圍繞食品安全和標籤的倫理爭論進一步削弱了市場信譽。在有機食品和天然食品運動盛行的地區,民眾的抵制也構成了推廣的障礙。這些擔憂也抑制了商業化投資,尤其是在法規結構嚴格的市場。因此,圍繞基改作物的倫理問題仍然是市場成長的一大威脅。
新冠疫情對農業合成生物學市場產生了複雜的影響。供應鏈中斷導致研究計劃延期,基因改造材料的取得受限,減緩了部分地區的應用。疫情期間,農民面臨財務不確定性,減少了對先進生物技術的投資。然而,疫情也凸顯了建構永續的糧食系統的重要性,重新激發了人們對合成生物學的興趣。遠端協作和數位化平台助力研究和商業化進程在限制條件下得以繼續進行。各國政府優先考慮糧食安全,加速了對創新農業技術的投入。
預計在預測期內,基因改造種子和性狀細分市場將佔據最大的市場佔有率。
由於基因改造種子和性狀能夠培育產量抗病作物,預計在預測期內,該領域將佔據最大的市場佔有率。合成生物學能夠實現精準的基因改造,進而提高作物的營養效率、抗病蟲害能力和氣候適應性。農民受益於投入成本的降低和生產力的提高,這進一步推動了對基因改造性狀的需求。生技和種子企業的大力投資也鞏固了該領域的領先地位。基因改造技術在商業農業中的廣泛應用進一步強化了其市場主導地位。對永續作物生產日益成長的需求與基因改造種子的優勢直接契合。
預計種子處理細分市場在預測期內將呈現最高的複合年成長率。
由於作物抗性的提高,種子處理領域預計將在預測期內實現最高成長率。合成生物學在微生物包衣和生物基處理方面的創新提高了種子發芽率,並能有效防治病蟲害。農民擴大採用種子處理技術,將其作為化學農藥的經濟有效的替代方案。人們對永續農業實踐的日益重視也推動了對生物基種子解決方案的需求。生物技術的進步使得處理方法更有效率和精準,從而促進了其應用。該領域受益於其擴充性和與多種作物類型的兼容性。
由於北美擁有先進的農業基礎設施,預計在預測期內將佔據最大的市場佔有率。美國和加拿大的農民正在利用合成生物學來提高生產力和永續性。大型生物技術和種子企業的強大影響力正在加速基因改造性狀的商業化。與其他地區相比,北美的政府支持和法規結構提供了相對清晰的指南。人們對永續作物生產的高度重視進一步增強了市場需求。對研究機構的投資和合作正在強化創新管道。
在預測期內,亞太地區預計將成為複合年成長率最高的地區,這主要得益於農業的快速現代化。中國、印度和澳洲等國家正大力推廣合成生物學技術,以提高作物抗性。不斷壯大的中產階級和日益成長的可支配收入推動了高級產品的普及。政府為促進永續農業和生物技術發展而採取的措施也進一步刺激了市場需求。該地區的農民越來越意識到抗蟲害和生物基解決方案的益處。電子商務和數位平台的興起,使得合成生物學產品更容易被不同市場所接受。
According to Stratistics MRC, the Global Synthetic Biology in Agriculture Market is accounted for $8.2 billion in 2025 and is expected to reach $82.7 billion by 2032 growing at a CAGR of 38.9% during the forecast period. Synthetic biology in agriculture is an interdisciplinary field that combines biology, engineering, and computational sciences to design and construct novel biological systems or modify existing organisms for agricultural purposes. It focuses on creating crops with enhanced traits such as improved yield, resistance to pests and diseases, drought tolerance, and optimized nutrient content. By engineering microorganisms, plants, and enzymes, synthetic biology can also improve soil health, enable sustainable fertilizer production, and develop bio-based pesticides. This approach aims to increase agricultural efficiency, reduce environmental impact, and support food security by harnessing precise, programmable biological solutions.
Rising demand for sustainable crop production
Farmers and agribusinesses are increasingly adopting synthetic biology solutions to reduce reliance on chemical inputs and enhance resource efficiency. Engineered seeds and microbial solutions enable higher yields while minimizing environmental impact, aligning with global sustainability goals. Growing consumer preference for eco-friendly food production further accelerates adoption of synthetic biology technologies. Governments and international organizations are promoting sustainable farming practices, reinforcing demand for innovative biological tools. The ability of synthetic biology to create resilient crops supports long-term food security.
Limited awareness among small-scale farmers
Many farmers remain unfamiliar with synthetic biology applications and their benefits, slowing adoption in fragmented agricultural systems. Lack of access to training and extension services further exacerbates this challenge. High complexity of technologies and perceived risks discourage smallholders from experimenting with engineered solutions. Limited awareness also restricts demand in emerging economies where traditional practices dominate. Without targeted education and outreach, adoption will remain concentrated among large-scale commercial farms.
Growing need for pest-resistant crop varieties
Synthetic biology enables the development of engineered seeds and microbial traits that enhance resilience against pests and diseases. Rising crop losses due to climate change and evolving pest pressures are driving demand for such solutions. Farmers benefit from reduced pesticide use, lower costs, and improved productivity, reinforcing adoption. Advances in genetic engineering and CRISPR technologies are accelerating innovation in pest-resistant traits. Governments and research institutions are supporting development programs to strengthen food security.
Ethical concerns over genetically modified crops
Consumer skepticism about genetic engineering and perceived risks to biodiversity limit acceptance in several regions. Advocacy groups often raise concerns about long-term ecological impacts, slowing regulatory approvals. Ethical debates around food safety and labeling further challenge market credibility. Public resistance in regions with strong organic and natural food movements creates barriers to adoption. These concerns also discourage investment in commercialization, particularly in markets with strict regulatory frameworks. Consequently, ethical issues surrounding genetically modified crops remain a critical threat to market growth.
The COVID-19 pandemic had a mixed impact on the Synthetic Biology in Agriculture market. Supply chain disruptions delayed research projects and restricted access to engineered inputs, slowing adoption in several regions. Farmers faced financial uncertainty, reducing investment in advanced biological solutions during the crisis. However, the pandemic highlighted the importance of resilient and sustainable food systems, driving renewed interest in synthetic biology. Remote collaboration and digital platforms supported ongoing research and commercialization despite restrictions. Governments emphasized food security, accelerating funding for innovative agricultural technologies.
The engineered seeds & traits segment is expected to be the largest during the forecast period
The engineered seeds & traits segment is expected to account for the largest market share during the forecast period due to its ability to deliver high-yield and resilient crops. Synthetic biology enables precise genetic modifications that enhance nutrient efficiency, pest resistance, and climate adaptability. Farmers benefit from reduced input costs and improved productivity, reinforcing demand for engineered traits. The segment's dominance is further supported by strong investment from biotech firms and seed companies. Widespread adoption in commercial farming operations strengthens its market leadership. Rising demand for sustainable crop production aligns directly with the benefits of engineered seeds.
The seed treatment segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the seed treatment segment is predicted to witness the highest growth rate owing to enhanced crop resilience. Synthetic biology innovations in microbial coatings and bio-based treatments improve germination rates and protect against pests and diseases. Farmers are increasingly adopting seed treatments as cost-effective alternatives to chemical pesticides. Rising awareness of sustainable farming practices accelerates demand for bio-based seed solutions. Advances in biotechnology are enabling more effective and targeted treatments, strengthening adoption. The segment benefits from scalability and compatibility with diverse crop types.
During the forecast period, the North America region is expected to hold the largest market share driven by advanced agricultural infrastructure. Farmers in the United States and Canada are leveraging synthetic biology to enhance productivity and sustainability. Strong presence of leading biotech firms and seed companies accelerates commercialization of engineered traits. Government support and regulatory frameworks provide relatively clearer guidance compared to other regions. High awareness of sustainable crop production further reinforces demand. Investment in research institutions and collaborations strengthens innovation pipelines.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR by rapid agricultural modernization. Countries such as China, India, and Australia are increasingly adopting synthetic biology to improve crop resilience. Expanding middle-class populations and increasing disposable incomes support premium product adoption. Government initiatives promoting sustainable farming and biotechnology further boost demand. Farmers in the region are becoming more aware of the benefits of pest-resistant and bio-based solutions. E-commerce and digital platforms are making synthetic biology products more accessible across diverse markets.
Key players in the market
Some of the key players in Synthetic Biology in Agriculture Market include Bayer AG, Corteva Agriscience, Syngenta Group, BASF SE, Novozymes, Ginkgo Bioworks, Pivot Bio, Indigo Agriculture, Benson Hill, Evogene, Zymergen, Amyris, Agrivida, GreenLight Biosciences and Tropic Biosciences.
In February 2024, Corteva launched its novel Lumidax(R) biofungicide in Canada. This product, based on the proprietary Pseudomonas chlororaphis strain, exemplifies synthetic biology by using a naturally occurring bacterium to protect roots and leaves from major fungal diseases. This launch underscores Corteva's commitment to expanding its portfolio of effective, sustainable biological solutions for growers.
In October 2023, Bayer announced a significant €220 million investment to expand its Biologics Center of Excellence and the manufacturing site in West Sacramento, California. This expansion is specifically aimed at scaling up the production and development of its biological crop protection products, including those derived from synthetic biology partnerships.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.